- Home
- HFFG vs ONCY Comparison
HFFG vs ONCY Comparison
Compare HFFG & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HFFG | ONCY |
|---|---|---|
| Founded | 1997 | 1998 |
| Country | United States | Canada |
| Employees | 960 | N/A |
| Industry | Food Distributors | Pharmaceuticals and Biotechnology |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 108.7M | 94.0M |
| IPO Year | 2016 | 2002 |
Fundamental Metrics
Financial Performance| Metric | HFFG | ONCY |
|---|---|---|
| Price | $2.02 | $0.96 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | $6.00 | ★ $7.33 |
| AVG Volume (30 Days) | 215.0K | ★ 740.9K |
| Earning Date | 05-11-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.65 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,228,282,000.00 | N/A |
| Revenue This Year | $5.35 | N/A |
| Revenue Next Year | $2.47 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 2.21 | N/A |
| 52 Week Low | $1.38 | $0.33 |
| 52 Week High | $4.47 | $1.51 |
Technical Indicators
Market Signals| Indicator | HFFG | ONCY |
|---|---|---|
| Relative Strength Index (RSI) | 57.23 | 50.59 |
| Support Level | $1.72 | $0.90 |
| Resistance Level | $2.34 | $1.08 |
| Average True Range (ATR) | 0.16 | 0.06 |
| MACD | 0.01 | -0.00 |
| Stochastic Oscillator | 50.77 | 69.35 |
Price Performance
Historical ComparisonAbout HFFG HF Foods Group Inc.
HF Foods Group Inc is an Asian food service distributor that markets and distributes fresh produce, seafood, frozen and dry food, and non-food products to Asian restaurants and other food service customers throughout the United States. The company's business consists of one operating segment; HF Group, which operates solely in the United States. The company's customer base consists of Chinese and Asian restaurants, and it provides sales and service support to customers who mainly converse in Mandarin or Chinese dialects.
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.